PlainRecalls
FDA Drug Moderate Class II Ongoing

Daytrana (methylphenidate transdermal system) CII, 10mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5552-3.

Reported: March 29, 2023 Initiated: March 10, 2023 #D-0470-2023

Product Description

Daytrana (methylphenidate transdermal system) CII, 10mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5552-3.

Reason for Recall

Defective Delivery System: Out of specification for shear.

Details

Recalling Firm
Noven Pharmaceuticals Inc
Units Affected
N/A
Distribution
US Nationwide
Location
Miami, FL

Frequently Asked Questions

What product was recalled?
Daytrana (methylphenidate transdermal system) CII, 10mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5552-3.. Recalled by Noven Pharmaceuticals Inc. Units affected: N/A.
Why was this product recalled?
Defective Delivery System: Out of specification for shear.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 29, 2023. Severity: Moderate. Recall number: D-0470-2023.